Names and pronunciation
(oh-lar-at′ue-mab) Lartruvo
PDF page 978
Loading InternPractice…
Drug reference
(oh-lar-at′ue-mab) Lartruvo
PDF page 978
Func. class.: Antineoplastic, monoclo- nal antibody
PDF page 978
USES: The treatment of soft-tissue sar- coma not amenable to curative treatment with radiotherapy or surgery, in combi- nation with DOXOrubicin
PDF page 978
CONTRAINDICATIONS: Hyper- sensitivity, pregnancy
PDF page 978
DOSAGE AND ROUTES • Adult: IV INFUSION 15 mg/kg over 60 min on days 1 and 8 repeated q21days until disease progression or unaccept- able toxicity in combination with doxoru- bicin 75 mg/m2 IV on day 1 repeated q21days for up to 8 cycles
PDF page 979
Available forms: Injection 190 mg/19 mL, 500 mg/50 mL (single use)
PDF page 979
• Adult: IV INFUSION 15 mg/kg over 60 min on days 1 and 8 repeated q21days until disease progression or unaccept- able toxicity in combination with doxoru- bicin 75 mg/m2 IV on day 1 repeated q21days for up to 8 cycles
PDF page 979